Skip to main content
PolicySpeak
← All files
KSS

Karl Storz SE & Co. KG

Company · Germany · EU Transparency Register 128633195168-72

2
positions filed
in the 326 files tracked
1
legislative file
of 326 tracked
2
with a full position paper
attached to a submission

Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.

Who they are

Among the 925 companies & groups on this site, they rank #543 by legislative files engaged — a count of participation, not a measure of influence.

0.2
declared lobbying FTE
self-declared
€50K+
declared costs / yr (floor)
0
EP accreditations
as declared to the register
2024
in the register since

Declares membership of

  • Registerrelevante Mitgliedschaften in Verbände
  • Vereinigungen
  • Dachverbände
  • Netzwerke oder sonstige Strukturen:
  • SPECTARIS - Deutscher Industrieverband für Optik
  • Photonik
  • Analysen- und Medizintechnik e.V.
  • Wirtschaftsrat der CDU e.V.
  • Der Bundesverband Gesundheits-IT - bvitg e.V.
  • Unternehmer Baden-Württemberg
  • econsense - Forum Nachhaltige Entwicklung der Deutschen Wirtschaft e. V.
  • Bundesverbandes der Deutschen Sicherheits-und Verteidigungsindustrie e.V. - BDSV
  • and 2 more

Self-declared to the EU Transparency Register (snapshot 30 Aug 2026).

Register category
Companies & groups
Registered as
KARL STORZ SE & Co. KG
Head office
Tuttlingen, Germany

Self-declared to the EU Transparency Register (snapshot 30 Aug 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.

Track Karl in PolicySpeak: request access →

Work at Karl Storz SE & Co. KG? so we know who speaks for it.

Follow the file Karl Storz SE & Co. KG engages with

One email on Tuesdays when a new position is filed on this file, from Karl Storz SE & Co. KG or from anyone else on it. Only when there is something new.

We use your email for these updates, and PolicySpeak may contact you about the product. Unsubscribe in one click. Privacy policy.

Their record over time

Karl Storz SE & Co. KG filed 2 positions between 6 Oct 2025 and 21 Jul 2026, across 1 of the 326 legislative files tracked here, attaching a full position paper 2 times.

2025 · 1 filed2026 · 1 filed

What they argued

Simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and support of the European Medicines Agency for the expert panels on medical devices and the list of Union harmonisation legislationfiled 21 Jul 2026PDFsource

KARL STORZ SE & Co. KG welcomes the European Commissions targeted MDR revision and supports a more proportionate, efficient and innovation-friendly framework while maintaining high patient safety standards. Positive elements include Well-Established Technologies (WET), broader acceptance of non-clinical evidence, greater recognition of equivalence and selected simplification measures.

Simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and support of the European Medicines Agency for the expert panels on medical devices and the list of Union harmonisation legislationfiled 6 Oct 2025PDFsource

Critical areas requiring urgent action in the upcoming targeted revision of the MDR include: 0. Harmonization of definitions across MDR and accompanying legal documents. 1. Proportionate Recertification and QMS Audits Manufacturers call for a shift from full re-assessments to change-based reviews during recertification.

Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.

Is this your organization?

Everything on this page comes from Karl Storz SE & Co. KG’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.

Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.